Detection of two partially structured species in the folding process of the amyloidogenic protein β2-microglobulin

Journal of Molecular Biology

Volumn 307, Issue 1, 2001, Pages 379-391

  Chiti, Fabrizio ^a   Mangione, Palma ^b   Andreola, Alessia ^c   Giorgetti, Sofia ^b   Stefani, Massimo ^a   Dobson, Christopher M ^d   Bellotti, Vittorio ^b,c   Taddei, Niccolò ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Amyloid fibrils; Dialysis related amyloidosis; Folding intermediates; Protein folding; 2 microglobulin

Indexed keywords

8 ANILINO 1 NAPHTHALENESULFONIC ACID; AMYLOID; AMYLOID PROTEIN; BETA 2 MICROGLOBULIN; CYCLOPHILIN; GUANIDINE; PROLINE; WATER;

AMINO TERMINAL SEQUENCE; AMYLOIDOSIS; ARTICLE; CHEMICAL BOND; CIRCULAR DICHROISM; FLUORESCENCE SPECTROSCOPY; HEMODIALYSIS; IN VITRO STUDY; ISOMERISM; KINETICS; PATHOGENESIS; PH; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN STRUCTURE; STRUCTURE ANALYSIS;

GOES;

EID: 0035896018     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.4478     Document Type: Article

References (37)

1. β2-microglobulin can be refolded into a native state from ex vivo amyloid fibrils
2. Biological activity and pathological implications of misfolded proteins
3. Structure of the human class I hystocompatibility antigen, HLA-A2
4. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
5. Consideration of the possibility that thez slow step in protein denaturation reactions is due to cis-trans isomerism of proline residues
6. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases
7. Detection and characterization of a folding intermediate in barnase by NMR
8. Mechanistic studies of the folding of human lysozyme and the origin of amyloidogenic behavior in its disease-related variants
9. Development of enzymatic activity during protein folding. Detection of a spectroscopically silent native-like intermediate of muscle acylphosphatase
10. Understanding protein folding via free-energy surfaces from theory and experiment
11. Protein misfolding, evolution and disease
12. The fundamentals of protein folding: Bringing together theory and experiment
13. Protein folding: A perspective from theory and experiment
14. Early steps in cytochrome c folding probed by time-resolved circular dichroism and fluorescence spectroscopy
15. Removal of the N-terminal hexapeptide from human β2-microglobulin facilitates protein aggregation and fibril formation
16. The structure, stability, and folding process of amyloidogenic mutant human lysozyme
17. Folding of chymotrypsin inhibitor 2. 1. Evidence for a two-state transition
18. Folding of chymotrypsin inhibitor 2. 2. Influence of proline isomerisation on the folding kinetics and thermodynamics characterisation of the transition state of folding
19. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways
20. Rational design of potent human transthyretin amyloid disease inhibitor
21. Comparison of the transient folding intermediates in lysozyme and alpha-lactalbumin
22. Catalysis of protein folding by prolyl isomerase
23. Transient folding intermediates characterized by protein engineering
24. Partially unfolded states of β2-microglobulin and amyloid formation in vitro
25. Inhibiting transthyretin amyloid fibril formation via protein stabilization
26. Proline isomerisation as a rate-limiting step
27. Amyloidosis
28. A comparison of the folding kinetics and thermodynamics of two homologous fibronectin type III modules
29. The folding of hen lysozyme involves partially structured intermediates and multiple pathways
30. Structural characterization of folding intermediates in cytochrome c by H-exchange labelling and proton NMR
31. Unfolding free-energy changes determined by the linear extrapolation method. 1. Unfolding of phenyl-methanesulfonyl alpha-chymotrypsin using different denaturants
32. Prolyl isomerase: Its role in protein folding and speculation on its function in the cell
33. The refolding of cis- and trans-peptidylprolyl isomers of barstar
34. Fast association rates suggest a conformational change in the MHC class I molecule H-2Db upon peptide binding
35. NMR evidence for an early framework intermediate on the folding pathway of ribonuclease A
36. Partially folded states of equine lysozyme. Structural characterization and significance for protein folding
37. Slow folding of muscle acylphosphatase in the absence of intermediates